BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas R, Wang HJ, Tsai PC, Langford CF, Fosmire SP, Jubala CM, Getzy DM, Cutter GR, Modiano JF, Breen M. Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 2009;17:365-77. [PMID: 19337847 DOI: 10.1007/s10577-009-9028-z] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Vail DM, Thamm DH. Spontaneous Companion Animal (Pet) Cancers. In: Teicher BA, editor. Tumor Models in Cancer Research. Totowa: Humana Press; 2011. pp. 353-73. [DOI: 10.1007/978-1-60761-968-0_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Jark PC, Mundin DB, de Carvalho M, Ferioli RB, Anai LA, Marchi FA, Rogatto SR, Laufer-Amorim R, Tinucci-Costa M. Genomic copy number variation associated with clinical outcome in canine cutaneous mast cell tumors. Res Vet Sci 2017;111:26-30. [PMID: 28266316 DOI: 10.1016/j.rvsc.2016.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Dobson JM. Breed-predispositions to cancer in pedigree dogs. ISRN Vet Sci 2013;2013:941275. [PMID: 23738139 DOI: 10.1155/2013/941275] [Cited by in Crossref: 125] [Cited by in F6Publishing: 110] [Article Influence: 13.9] [Reference Citation Analysis]
4 Sapierzyński R, Czopowicz M. The animal-dependent risk factors in canine osteosarcomas. Pol J Vet Sci 2017;20:293-8. [PMID: 28865206 DOI: 10.1515/pjvs-2017-0035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
5 Beck J, Hennecke S, Bornemann-Kolatzki K, Urnovitz HB, Neumann S, Ströbel P, Kaup FJ, Brenig B, Schütz E. Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One 2013;8:e75485. [PMID: 24098698 DOI: 10.1371/journal.pone.0075485] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
6 Scott MC, Sarver AL, Gavin KJ, Thayanithy V, Getzy DM, Newman RA, Cutter GR, Lindblad-Toh K, Kisseberth WC, Hunter LE, Subramanian S, Breen M, Modiano JF. Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. Bone 2011;49:356-67. [PMID: 21621658 DOI: 10.1016/j.bone.2011.05.008] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
7 Grüntzig K, Graf R, Boo G, Guscetti F, Hässig M, Axhausen K, Fabrikant S, Welle M, Meier D, Folkers G, Pospischil A. Swiss Canine Cancer Registry 1955–2008: Occurrence of the Most Common Tumour Diagnoses and Influence of Age, Breed, Body Size, Sex and Neutering Status on Tumour Development. Journal of Comparative Pathology 2016;155:156-70. [DOI: 10.1016/j.jcpa.2016.05.011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
8 Maeda J, Yurkon CR, Fujisawa H, Kaneko M, Genet SC, Roybal EJ, Rota GW, Saffer ER, Rose BJ, Hanneman WH, Thamm DH, Kato TA. Genomic instability and telomere fusion of canine osteosarcoma cells. PLoS One 2012;7:e43355. [PMID: 22916246 DOI: 10.1371/journal.pone.0043355] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
9 Hedan B, Thomas R, Motsinger-Reif A, Abadie J, Andre C, Cullen J, Breen M. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer 2011;11:201. [PMID: 21615919 DOI: 10.1186/1471-2407-11-201] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
10 Rankin KS, Starkey M, Lunec J, Gerrand CH, Murphy S, Biswas S. Of dogs and men: Comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma. Pediatr Blood Cancer 2012;58:327-33. [DOI: 10.1002/pbc.23341] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
11 Rowell JL, McCarthy DO, Alvarez CE. Dog models of naturally occurring cancer. Trends Mol Med 2011;17:380-8. [PMID: 21439907 DOI: 10.1016/j.molmed.2011.02.004] [Cited by in Crossref: 226] [Cited by in F6Publishing: 202] [Article Influence: 20.5] [Reference Citation Analysis]
12 Zandvliet M. Canine lymphoma: a review. Veterinary Quarterly 2016;36:76-104. [DOI: 10.1080/01652176.2016.1152633] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
13 Angstadt AY, Thayanithy V, Subramanian S, Modiano JF, Breen M. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations. Cancer Genet 2012;205:572-87. [PMID: 23137772 DOI: 10.1016/j.cancergen.2012.09.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
14 Marconato L, Gelain ME, Comazzi S. The dog as a possible animal model for human non-Hodgkin lymphoma: a review. Hematol Oncol 2013;31:1-9. [PMID: 22674797 DOI: 10.1002/hon.2017] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 9.0] [Reference Citation Analysis]
15 Shearin AL, Ostrander EA. Leading the way: canine models of genomics and disease. Dis Model Mech 2010;3:27-34. [PMID: 20075379 DOI: 10.1242/dmm.004358] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 8.8] [Reference Citation Analysis]
16 Zapata I, Moraes LE, Fiala EM, Zaldivar-Lopez S, Couto CG, Rowell JL, Alvarez CE. Risk-modeling of dog osteosarcoma genome scans shows individuals with Mendelian-level polygenic risk are common. BMC Genomics 2019;20:226. [PMID: 30890123 DOI: 10.1186/s12864-019-5531-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gustafson DL, Duval DL, Regan DP, Thamm DH. Canine sarcomas as a surrogate for the human disease. Pharmacol Ther 2018;188:80-96. [PMID: 29378221 DOI: 10.1016/j.pharmthera.2018.01.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
18 Pazzaglia L, Leonardi L, Conti A, Novello C, Quattrini I, Montanini L, Roperto F, Del Piero F, Di Guardo G, Piro F, Picci P, Benassi MS. miR-196a expression in human and canine osteosarcomas: A comparative study. Research in Veterinary Science 2015;99:112-9. [DOI: 10.1016/j.rvsc.2014.12.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
19 Thayanithy V, Park C, Sarver AL, Kartha RV, Korpela DM, Graef AJ, Steer CJ, Modiano JF, Subramanian S. Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. PLoS One 2012;7:e43720. [PMID: 22957032 DOI: 10.1371/journal.pone.0043720] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
20 Atherton MJ, Lenz JA, Mason NJ. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy? Vet Comp Oncol 2020;18:447-70. [PMID: 32246517 DOI: 10.1111/vco.12595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Heishima K, Meuten T, Yoshida K, Mori T, Thamm DH. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy. BMC Vet Res 2019;15:39. [PMID: 30683101 DOI: 10.1186/s12917-019-1776-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 Gardner HL, Sivaprakasam K, Briones N, Zismann V, Perdigones N, Drenner K, Facista S, Richholt R, Liang W, Aldrich J, Trent JM, Shields PG, Robinson N, Johnson J, Lana S, Houghton P, Fenger J, Lorch G, Janeway KA, London CA, Hendricks WPD. Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2. Commun Biol 2019;2:266. [PMID: 31341965 DOI: 10.1038/s42003-019-0487-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
23 Alvarez CE. Naturally Occurring Cancers in Dogs: Insights for Translational Genetics and Medicine. ILAR Journal 2014;55:16-45. [DOI: 10.1093/ilar/ilu010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
24 Phillips JC, Lembcke L, Chamberlin T. A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26. Genomics 2010;96:220-7. [DOI: 10.1016/j.ygeno.2010.07.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
25 O'Donoghue LE, Ptitsyn AA, Kamstock DA, Siebert J, Thomas RS, Duval DL. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome. BMC Cancer 2010;10:506. [PMID: 20860831 DOI: 10.1186/1471-2407-10-506] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
26 Varshney J, Scott MC, Largaespada DA, Subramanian S. Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach. Vet Sci 2016;3:E3. [PMID: 29056713 DOI: 10.3390/vetsci3010003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
27 Thomas R, Valli VE, Ellis P, Bell J, Karlsson EK, Cullen J, Lindblad-Toh K, Langford CF, Breen M. Microarray-based cytogenetic profiling reveals recurrent and subtype-associated genomic copy number aberrations in feline sarcomas. Chromosome Res 2009;17:987-1000. [PMID: 19941159 DOI: 10.1007/s10577-009-9096-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
28 Thomas R, Rebbeck C, Leroi AM, Burt A, Breen M. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis. Chromosome Res 2009;17:927-34. [PMID: 19798471 DOI: 10.1007/s10577-009-9080-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
29 Russell DS, Jaworski L, Kisseberth WC. Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray. J Vet Diagn Invest 2018;30:504-9. [PMID: 29629647 DOI: 10.1177/1040638718770239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Gardner HL, Fenger JM, London CA. Dogs as a Model for Cancer. Annu Rev Anim Biosci 2016;4:199-222. [PMID: 26566160 DOI: 10.1146/annurev-animal-022114-110911] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
31 Cullen JM, Breen M. An Overview of Molecular Cancer Pathogenesis, Prognosis, and Diagnosis. In: Meuten DJ, editor. Tumors in Domestic Animals. Hoboken: John Wiley & Sons, Inc.; 2016. pp. 1-26. [DOI: 10.1002/9781119181200.ch1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Angstadt AY, Motsinger-Reif A, Thomas R, Kisseberth WC, Guillermo Couto C, Duval DL, Nielsen DM, Modiano JF, Breen M. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes Chromosomes Cancer 2011;50:859-74. [PMID: 21837709 DOI: 10.1002/gcc.20908] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
33 Gourbault O, Llobat L. MicroRNAs as Biomarkers in Canine Osteosarcoma: A New Future? Vet Sci 2020;7:E146. [PMID: 33008041 DOI: 10.3390/vetsci7040146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand 2017;59:71. [PMID: 29065898 DOI: 10.1186/s13028-017-0341-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 17.8] [Reference Citation Analysis]
35 Bennett PF, Taylor R, Williamson P. Demographic risk factors for lymphoma in Australian dogs: 6201 cases. J Vet Intern Med 2018;32:2054-60. [PMID: 30307659 DOI: 10.1111/jvim.15306] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
36 Shearman JR, Wilton AN. Origins of the domestic dog and the rich potential for gene mapping. Genet Res Int 2011;2011:579308. [PMID: 22567358 DOI: 10.4061/2011/579308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Xavier PLP, Müller S, Fukumasu H. Epigenetic Mechanisms in Canine Cancer. Front Oncol 2020;10:591843. [PMID: 33194754 DOI: 10.3389/fonc.2020.591843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Fenger JM, London CA, Kisseberth WC. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology. ILAR J 2014;55:69-85. [PMID: 24936031 DOI: 10.1093/ilar/ilu009] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 17.0] [Reference Citation Analysis]
39 Murphy BG, Mok MY, York D, Rebhun R, Woolard KD, Hillman C, Dickinson P, Skorupski K. Evaluation of P16 expression in canine appendicular osteosarcoma. BMC Vet Res 2017;13:189. [PMID: 28633676 DOI: 10.1186/s12917-017-1113-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Sadikovic B, Park PC, Selvarajah S, Zielenska M. Array comparative genomic hybridization in osteosarcoma. Methods Mol Biol 2013;973:227-47. [PMID: 23412794 DOI: 10.1007/978-1-62703-281-0_15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
41 Scott MC, Sarver AL, Tomiyasu H, Cornax I, Van Etten J, Varshney J, O'Sullivan MG, Subramanian S, Modiano JF. Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma. J Biol Chem 2015;290:28070-83. [PMID: 26378234 DOI: 10.1074/jbc.M115.679696] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
42 Seiser EL, Thomas R, Richards KL, Kelley MK, Moore P, Suter SE, Breen M. Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines. Vet Comp Oncol 2013;11:30-50. [PMID: 22236332 DOI: 10.1111/j.1476-5829.2011.00299.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
43 Stein TJ, Holmes KE, Muthuswamy A, Thompson V, Huelsmeyer MK. Characterization of β-catenin expression in canine osteosarcoma. Vet Comp Oncol 2011;9:65-73. [PMID: 21303455 DOI: 10.1111/j.1476-5829.2010.00236.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
44 Ehrhart NP, Ryan SD, Fan TM. Tumors of the Skeletal System. Withrow and MacEwen's Small Animal Clinical Oncology. Elsevier; 2013. pp. 463-503. [DOI: 10.1016/b978-1-4377-2362-5.00024-4] [Cited by in Crossref: 49] [Article Influence: 5.4] [Reference Citation Analysis]
45 Bongiovanni L, Mazzocchetti F, Malatesta D, Romanucci M, Ciccarelli A, Buracco P, De Maria R, Palmieri C, Martano M, Morello E, Maniscalco L, Della Salda L. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma. BMC Vet Res 2012;8:78. [PMID: 22686277 DOI: 10.1186/1746-6148-8-78] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
46 Tuohy JL, Shaevitz MH, Garrett LD, Ruple A, Selmic LE. Demographic characteristics, site and phylogenetic distribution of dogs with appendicular osteosarcoma: 744 dogs (2000-2015). PLoS One 2019;14:e0223243. [PMID: 31887114 DOI: 10.1371/journal.pone.0223243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Thomas R, Demeter Z, Kennedy KA, Borst L, Singh K, Valli VE, Le Boedec K, Breen M. Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of canine follicular lymphoma. Vet Comp Oncol 2017;15:852-67. [PMID: 27135201 DOI: 10.1111/vco.12227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
48 Ehrhart NP, Christensen NI, Fan TM. Tumors of the Skeletal System. Withrow and MacEwen's Small Animal Clinical Oncology. Elsevier; 2020. pp. 524-64. [DOI: 10.1016/b978-0-323-59496-7.00025-6] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Breen M. Update on genomics in veterinary oncology. Top Companion Anim Med 2009;24:113-21. [PMID: 19732729 DOI: 10.1053/j.tcam.2009.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
50 Modiano JF, Bellgrau D, Cutter GR, Lana SE, Ehrhart NP, Ehrhart E, Wilke VL, Charles JB, Munson S, Scott MC, Pozniak J, Carlson CS, Schaack J, Duke RC. Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther 2012;20:2234-43. [PMID: 22850679 DOI: 10.1038/mt.2012.149] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
51 Fan TM, Khanna C. Comparative Aspects of Osteosarcoma Pathogenesis in Humans and Dogs. Vet Sci 2015;2:210-30. [PMID: 29061942 DOI: 10.3390/vetsci2030210] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
52 Thomas R, Seiser EL, Motsinger-Reif A, Borst L, Valli VE, Kelley K, Suter SE, Argyle D, Burgess K, Bell J, Lindblad-Toh K, Modiano JF, Breen M. Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas. Leuk Lymphoma 2011;52:1321-35. [PMID: 21375435 DOI: 10.3109/10428194.2011.559802] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
53 Patatsos K, Shekhar TM, Hawkins CJ. Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma. Vet Comp Oncol 2018;16:544-53. [PMID: 29998615 DOI: 10.1111/vco.12413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
54 Barani M, Mukhtar M, Rahdar A, Sargazi S, Pandey S, Kang M. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma. Biosensors (Basel) 2021;11:55. [PMID: 33672770 DOI: 10.3390/bios11020055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]